Dr. Fariba M. Donovan, MD

Dr. Donovan practices at University of Arizona in Tucson, Arizona.

Dr. Donovan's NPI, 1295998292, was assigned on July 9, 2008. Dr. Donovan holds Florida license ME 100182.

Dr. Donovan's primary practice is University of Arizona, at 1501 N Campbell Ave, Tucson, AZ 85724 in Pima County. The practice phone is (520) 626-2761.

Dr. Donovan's primary practice is University of Arizona in Tucson, Arizona. Dr. Donovan is also affiliated with Banner - University Medical Center Tucson. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Donovan to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Donovan practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Donovan's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Donovan is licensed in Florida.

CMS data shows 138 Medicare services from Dr. Donovan across 5 procedure codes in 2024, for 78 Medicare patients. Medicare paid $12,362 for them.

CMS counts 78 Medicare patients who saw Dr. Donovan in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Donovan's median patient age at 63, with 46% women.

In 2024, Dr. Donovan wrote 160 Medicare Part D claims for 37 patients. 87% of them were for generic drugs. CMS names the drug for 145 of them, across 3 drugs with 11 or more claims each, at $181,799 in total drug cost. In 2023, CMS named 90 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Donovan for performance year 2024, reported through an alternative payment model (APM). Dr. Donovan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 46 papers to Dr. Donovan, published from 2011 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Coccidioidomycosis, Coccidioides and Antifungal Agents. Dr. Donovan has published most often in Phys Rev Lett. Dr. Donovan's most frequent co-authors are Eric Karl Gustafson, MD, Brett (Brick) A. Lantz, MD and Arthur Weinstein, MD.

Dmand AI links Dr. Donovan to 1 clinical trial. Conditions studied include Coccidioidomycosis and Mycoses.

CMS Open Payments shows 35 general payments to Dr. Donovan from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Astellas Pharma US Inc paid the most, $922.